BlockMed Pro Secures £250k Seed Funding to Monetise Electronic Health Records

Huddersfield-registered health-tech startup BlockMed Pro has raised £250k in a seed funding round, achieving an estimated post-money valuation of £1.2m.

Incorporated in July 2024, the software development company operates with a team of five. While registered in West Yorkshire, the firm maintains its headquarters in Abu Dhabi. BlockMed Pro is building a blockchain and artificial intelligence platform that enables patients to securely manage and monetise their electronic health records.

The company addresses the ongoing challenge of patient data ownership and the pharmaceutical industry's demand for reliable, real-world clinical data. Through its digital marketplace and integrated healthcare software systems, BlockMed Pro provides pharmaceutical and research partners with access to anonymised patient information.

The platform is designed to offer full interoperability between different healthcare specialities and systems. According to the company, every dataset is underpinned by explicit patient consent, clear provenance, and full auditability. This blockchain-backed approach allows data buyers to verify how the information was sourced and governed. Additionally, the platform utilises artificial intelligence to generate personalised health insights for users based on their own data.

The seed round, which was allotted on 12 March 2026 and filed on 25 March 2026, injects £250k of new capital into the early-stage business. This values BlockMed Pro at £1.2m post-money. Specific investors participating in the round were not disclosed in the regulatory filings. As a seed round for a recently incorporated business, there are no previous funding rounds for comparison. Financial metrics such as revenue and profit are not yet available for the 2024-founded company.

This early-stage investment reflects continued momentum within the UK health-tech and artificial intelligence sectors. Following a period of market correction, the broader UK health technology ecosystem was valued at £32 billion by the end of 2024, supported by a workforce of nearly 30,000 people. The sector's growth accelerated through 2025, with life sciences and health-tech companies securing £1.8 billion across 58 venture capital deals over the course of the year.

Furthermore, the intersection of healthcare and artificial intelligence continues to attract substantial capital. Industry data indicates that nearly half of all venture capital investment in the UK health sector during the first quarter of 2025 was directed toward AI-powered startups. BlockMed Pro's focus on secure data governance and Web3 infrastructure positions it within a specialised niche of founders attempting to commercialise health data while maintaining strict privacy and consent standards.